Literature DB >> 891035

Circulating immune complexes in retinal vasculitis.

B S Andrews, J McIntosh, V Petts, R Penny.   

Abstract

Seventeen patients with retinal vasculitis, eleven with the peripheral type (Eales' disease) and six with the central type, were investigated to detect the presence of circulating immune complexes (IC) which might then be related to the pathogenesis of their disease. A systemic disease process was identified in six. IC in serum were inferred by the presence of complement (C) activation, rheumatoid factor, Clq or monoclonal rheumatoid factor precipitins, anticomplementary activity, elevated cryoglobulins, inhibition of erythrocyte-antibody (IgG-EA) rosette formation, increased numbers of peripheral blood lymphocytes bearing surface Ig, and spontaneous neutrophil chemotatic activity in plasma. Two or more parameters were positive in thirteen of seventeen patients, with chemotactic activity (69%) and inhibition of EA-rosette formation (59%) being the most frequently positive tests. No immunological differences were detected between the peripheral and central retinal-vasculitis groups. Several IC systems may operate in a give patient.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 891035      PMCID: PMC1541047     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  11 in total

1.  RETINAL VASCULITIS.

Authors:  T K Lyle; K Wybar
Journal:  Br J Ophthalmol       Date:  1961-12       Impact factor: 4.638

2.  Vascular allergy; experimental studies on allergic thrombosis of the retinal veins.

Authors:  P DE MURO; M FOCOSI
Journal:  J Allergy       Date:  1951-03

3.  Cryoglobulins in vasculitis.

Authors:  J J Cream
Journal:  Clin Exp Immunol       Date:  1972-01       Impact factor: 4.330

4.  Experimental acute immunologic ocular vasculitis.

Authors:  R A Levine; P A Ward
Journal:  Am J Ophthalmol       Date:  1970-06       Impact factor: 5.258

5.  Benign retinal vasculitis. Clinical and fluorescein angiographic study.

Authors:  C D Hart; M D Sanders; S J Miller
Journal:  Br J Ophthalmol       Date:  1971-11       Impact factor: 4.638

6.  IgG on lymphocyte surfaces; technical problems and the significance of a third cell population.

Authors:  R J Winchester; S M Fu; T Hoffman; H G Kunkel
Journal:  J Immunol       Date:  1975-04       Impact factor: 5.422

7.  Precipitin reactions of the C1q component of complement with aggregated gamma-globulin and immune complexes in gel diffusion.

Authors:  V Agnello; R J Winchester; H G Kunkel
Journal:  Immunology       Date:  1970-12       Impact factor: 7.397

8.  Identification of two populations of immunoglobulin-bearing lymphocytes in man.

Authors:  P I Lobo; F B Westervelt; D A Horwitz
Journal:  J Immunol       Date:  1975-01       Impact factor: 5.422

9.  Detection of circulating immune complexes in pathological human sera.

Authors:  A H Johnson; J F Mowbray; K A Porter
Journal:  Lancet       Date:  1975-04-05       Impact factor: 79.321

10.  T and B cell populations in blood and lymph node in lymphoproliferative disease.

Authors:  D A Cooper; V Petts; E Luckhurst; J C Biggs; R Penny
Journal:  Br J Cancer       Date:  1975-05       Impact factor: 7.640

View more
  7 in total

1.  Circulating immune complexes may play a regulatory and pathogenic role in experimental autoimmune uveoretinitis.

Authors:  E Kasp; M R Stanford; E Brown; A G Coombes; D C Dumonde
Journal:  Clin Exp Immunol       Date:  1992-05       Impact factor: 4.330

Review 2.  Immune complexes in human diseases: a review.

Authors:  A N Theofilopoulos; F J Dixon
Journal:  Am J Pathol       Date:  1980-08       Impact factor: 4.307

3.  Serum-mediated inhibition of lymphocyte Fc gamma receptors in glomerulonephritis.

Authors:  A Bakkaloglu; G P Sandilands; J D Briggs; J R Anderson
Journal:  Clin Exp Immunol       Date:  1980-12       Impact factor: 4.330

4.  Immunological abnormalities in patients with untreated retinal vasculitis.

Authors:  D Wakefield; J Easter; R Penny
Journal:  Br J Ophthalmol       Date:  1986-04       Impact factor: 4.638

5.  Retinal vasculitis in rheumatoid arthritis.

Authors:  M F Martin; D G Scott; C Gilbert; P A Dieppe; D L Easty
Journal:  Br Med J (Clin Res Ed)       Date:  1981-05-30

6.  A longitudinal study of clinical and immunological findings in 52 patients with relapsing retinal vasculitis.

Authors:  M R Stanford; E Graham; E Kasp; M D Sanders; D C Dumonde
Journal:  Br J Ophthalmol       Date:  1988-06       Impact factor: 4.638

7.  Retinal vasculitis: a review.

Authors:  M D Sanders
Journal:  J R Soc Med       Date:  1979-12       Impact factor: 18.000

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.